BIO
Bio-Rad Laboratories, Inc. Class A · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website bio-rad.com
- Employees(FY) 8000
- ISIN US0905722072
Performance
-11.2%
1W
-6.55%
1M
-0.81%
3M
+10.15%
6M
+0.25%
YTD
+6.3%
1Y
Profile
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Technical Analysis of BIO 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-12 19:00
BIO: Lowering target price to $292.00(Argus Research)
- 2024-11-05 19:00
BIO: Raising target price to $299.00(Argus Research)
- 2024-11-02 08:23
- 2024-11-01 06:43
- 2024-10-31 11:52
Analyst Report: Bio-Rad Laboratories, Inc.(Morningstar Research)
- 2024-10-31 09:00
- 2024-10-30 21:00
- 2024-10-30 16:15
Bio-Rad Reports Third-Quarter 2024 Financial Results(Business Wire)
- 2024-10-30 04:15
Bio-Rad Reports Third-Quarter 2024 Financial Results(Businesswire)
- 2024-10-25 06:34
- 2024-10-14 17:30
- 2024-10-14 05:30
- 2024-10-08 20:00
BIO: Raising target price to $274.00(Argus Research)
- 2024-09-22 19:45
5 Things to Know Before the Stock Market Opens(Investopedia)
- 2024-09-21 18:00
- 2024-09-20 04:20
What Friday's Triple-Witching Means For You(Investopedia)
- 2024-09-09 22:56
- 2024-09-06 18:43
- 2024-09-06 06:43
- 2024-08-28 05:25
- 2024-08-27 20:00
BIO: Raising target price to $283.00(Argus Research)
- 2024-08-23 04:30
- 2024-08-22 16:30
- 2024-08-20 20:00
BIO: What does Argus have to say about BIO?(Argus Research)
- 2024-08-20 08:30
- 2024-08-19 20:30
- 2024-08-02 04:15
Bio-Rad Reports Second-Quarter 2024 Financial Results(Businesswire)
- 2024-08-01 16:15
Bio-Rad Reports Second-Quarter 2024 Financial Results(Business Wire)
- 2024-07-23 20:00
BIO: Lowering target price to $275.00(Argus Research)
- 2024-07-18 04:30
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.